COVID-19 Medicines governance arrangements
Interim NHSGGC Medicines Governance Processes During the COVID-19 Pandemic
In light of the COVID-19 pandemic, the NHSGGC Area Drug and Therapeutics Committee (ADTC) and its subcommittees, has cancelled its meetings for the next few months. To maintain medicines governance, a small ADTC Executive team will continue to consider any relevant business on a case-by-case basis. This business includes the consideration of any urgently required clinical guidelines containing medicines, particularly those related to COVID-19. The interim arrangements also cover requests for medicines on an individual patient basis (PACS2, IPTR, ULM etc) and Controlled Drug governance processes.
Further details of all these interim arrangements can be accessed HERE.
Published April 29th 2020. Medicines Update blogs are correct at the time of publication.